News

🍋 The War for Your Car's Screen

🍋 The War for Your Car's Screen

General Motors snubbed CarPlay for new EVs, Amazon is getting rid of free deliveries, and NYC hired a rat czar.

🍋 The War for Your Car's Screen

General Motors snubbed CarPlay for new EVs, Amazon is getting rid of free deliveries, and NYC hired a rat czar.

🍋 Big Tech's Innovation Problem

🍋 Big Tech's Innovation Problem

Big Tech inventors produce fewer patents after they are hired, Apollo's co-founder bought the Washington Commanders, and NYC rent hit a new record high.

🍋 Big Tech's Innovation Problem

Big Tech inventors produce fewer patents after they are hired, Apollo's co-founder bought the Washington Commanders, and NYC rent hit a new record high.

Insiders:💰How The World is Changing

Insiders:💰How The World is Changing

Weekly alpha-generating and thought-provoking newsletter by Short Squeez Insiders.

Insiders:💰How The World is Changing

Weekly alpha-generating and thought-provoking newsletter by Short Squeez Insiders.

🍋 AI Coming for Lawyers

🍋 AI Coming for Lawyers

AI is coming for lawyers' jobs, inflation was lower in March, and the Fed thinks we're heading for a recession.

🍋 AI Coming for Lawyers

AI is coming for lawyers' jobs, inflation was lower in March, and the Fed thinks we're heading for a recession.

🍋 Private Equity's Food Fiasco

🍋 Private Equity's Food Fiasco

Private equity investors are getting burned after the food industry was less recession-proof than previously thought, Bitcoin surged to $30k, and the FBI reveals the reason you shouldn't use public...

🍋 Private Equity's Food Fiasco

Private equity investors are getting burned after the food industry was less recession-proof than previously thought, Bitcoin surged to $30k, and the FBI reveals the reason you shouldn't use public...

🤝 Insiders: The Business of Adderall

🤝 Insiders: The Business of Adderall

Insiders Investment Newsletter: Mental Health Drug Industry Deep-dive

🤝 Insiders: The Business of Adderall

Insiders Investment Newsletter: Mental Health Drug Industry Deep-dive